2020 Q4 Form 10-Q Financial Statement
#000121390020037298 Filed on November 16, 2020
Income Statement
Concept | 2020 Q4 | 2020 Q3 | 2020 Q2 |
---|---|---|---|
Revenue | $4.110M | $3.714M | $3.004M |
YoY Change | 24.17% | 16.32% | -17.03% |
Cost Of Revenue | $1.400M | $1.740M | $1.819M |
YoY Change | -13.33% | 26.11% | 68.39% |
Gross Profit | $2.710M | $1.974M | $1.185M |
YoY Change | 60.26% | 8.87% | -53.34% |
Gross Profit Margin | 65.94% | 53.15% | 39.45% |
Selling, General & Admin | $3.800M | $4.568M | $5.243M |
YoY Change | -22.18% | 26.82% | -60.1% |
% of Gross Profit | 140.22% | 231.38% | 442.43% |
Research & Development | $1.410M | $1.759M | $1.089M |
YoY Change | 126.14% | 187.91% | -59.52% |
% of Gross Profit | 52.03% | 89.1% | 91.89% |
Depreciation & Amortization | $840.0K | $1.171M | $1.320M |
YoY Change | 6442.39% | ||
% of Gross Profit | 31.0% | 59.32% | 111.39% |
Operating Expenses | $6.040M | $7.498M | $7.368M |
YoY Change | 9.69% | 77.98% | -12.18% |
Operating Profit | -$3.330M | -$5.523M | -$6.183M |
YoY Change | -12.73% | 130.2% | 5.7% |
Interest Expense | -$1.930M | -$3.687K | -$2.084K |
YoY Change | -3960.0% | -105.27% | -110.42% |
% of Operating Profit | |||
Other Income/Expense, Net | -$60.00K | $1.537M | $157.0K |
YoY Change | 2002.69% | ||
Pretax Income | -$12.20M | -$3.987M | -$6.026M |
YoY Change | 181.11% | 71.36% | 3.55% |
Income Tax | $0.00 | $30.99K | |
% Of Pretax Income | |||
Net Earnings | -$12.22M | -$3.979M | -$5.313M |
YoY Change | 224.68% | 71.05% | -8.72% |
Net Earnings / Revenue | -297.32% | -107.14% | -176.87% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$811.4K | -$337.1K | -$221.6K |
COMMON SHARES | |||
Basic Shares Outstanding | 19.69M shares | 14.69M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2020 Q4 | 2020 Q3 | 2020 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $17.84M | $14.26M | $24.16M |
YoY Change | -5.01% | -36.42% | 10.47% |
Cash & Equivalents | $17.84M | $14.26M | $24.16M |
Short-Term Investments | |||
Other Short-Term Assets | $2.960M | $1.980M | $1.710M |
YoY Change | 83.85% | 44.53% | 58.33% |
Inventory | |||
Prepaid Expenses | $2.459M | $1.215M | |
Receivables | $1.754M | $2.799M | $1.862M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $22.55M | $19.03M | $27.73M |
YoY Change | 1.87% | -27.66% | 14.59% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.193M | $1.396M | $131.1K |
YoY Change | |||
Goodwill | $41.87M | $46.50M | $20.25M |
YoY Change | 106.74% | ||
Intangibles | $7.389M | ||
YoY Change | |||
Long-Term Investments | $233.7K | $240.0K | $250.0K |
YoY Change | -6.53% | ||
Other Assets | $41.93K | $41.93K | |
YoY Change | |||
Total Long-Term Assets | $54.62M | $62.30M | $30.80M |
YoY Change | 21746.46% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $22.55M | $19.03M | $27.73M |
Total Long-Term Assets | $54.62M | $62.30M | $30.80M |
Total Assets | $77.17M | $81.33M | $58.53M |
YoY Change | 244.66% | 209.14% | 141.84% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $513.6K | $6.000M | $1.444M |
YoY Change | -69.24% | 275.0% | 9.59% |
Accrued Expenses | $3.420M | ||
YoY Change | 584.0% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $2.000M | $0.00 |
YoY Change | |||
Long-Term Debt Due | $11.71M | $10.15M | $6.140M |
YoY Change | |||
Total Short-Term Liabilities | $16.05M | $18.13M | $11.75M |
YoY Change | 421.14% | 504.39% | 381.27% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $3.895M | $5.480M | $10.20M |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $3.895M | $5.480M | $10.20M |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $16.05M | $18.13M | $11.75M |
Total Long-Term Liabilities | $3.895M | $5.480M | $10.20M |
Total Liabilities | $19.95M | $23.61M | $23.01M |
YoY Change | 547.61% | 687.11% | 319.61% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$57.18M | $0.20 | -$41.15M |
YoY Change | 49.21% | ||
Common Stock | $94.09M | $83.17M | $71.90M |
YoY Change | 55.3% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $57.22M | $57.72M | $35.52M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $77.17M | $81.33M | $58.53M |
YoY Change | 244.66% | 209.14% | 141.84% |
Cashflow Statement
Concept | 2020 Q4 | 2020 Q3 | 2020 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$12.22M | -$3.979M | -$5.313M |
YoY Change | 224.68% | 71.05% | -8.72% |
Depreciation, Depletion And Amortization | $840.0K | $1.171M | $1.320M |
YoY Change | 6442.39% | ||
Cash From Operating Activities | -$4.530M | -$4.181M | -$2.750M |
YoY Change | 14.97% | 33.07% | 2.23% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.220M | -$640.0K | -$3.260M |
YoY Change | 23.08% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$210.0K | -$5.070M | -$140.0K |
YoY Change | -16.0% | -100.74% | |
Cash From Investing Activities | -$1.440M | -$5.705M | -$3.400M |
YoY Change | -633.33% | 997.63% | -118.05% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 9.540M | -$12.67K | 15.98M |
YoY Change | 95300.0% | -100.3% | |
NET CHANGE | |||
Cash From Operating Activities | -4.530M | -$4.181M | -2.750M |
Cash From Investing Activities | -1.440M | -$5.705M | -3.400M |
Cash From Financing Activities | 9.540M | -$12.67K | 15.98M |
Net Change In Cash | 3.570M | -$9.898M | 9.830M |
YoY Change | -197.54% | -1804.96% | -39.13% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$4.530M | -$4.181M | -$2.750M |
Capital Expenditures | -$1.220M | -$640.0K | -$3.260M |
Free Cash Flow | -$3.310M | -$3.541M | $510.0K |
YoY Change | 35.05% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
131095 | USD |
CY2020Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2667349 | shares |
CY2020Q3 | us-gaap |
Liabilities
Liabilities
|
23613226 | USD |
CY2020Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
5998001 | USD |
CY2020Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
41925 | USD |
CY2020Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4861928 | USD |
CY2020Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
31870154 | USD |
CY2020Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1395690 | USD |
CY2020Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1475613 | USD |
CY2020Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
1321 | USD |
CY2020Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11754977 | USD |
CY2020Q3 | us-gaap |
Minority Interest
MinorityInterest
|
USD | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
57721556 | USD |
CY2019Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.21 | |
CY2020Q3 | kern |
Capitalized Software Net
CapitalizedSoftwareNet
|
3389646 | USD |
CY2020Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2020Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
81334782 | USD |
CY2020Q2 | us-gaap |
Minority Interest
MinorityInterest
|
4704252 | USD |
CY2020Q3 | kern |
Current Contingent Consideration
CurrentContingentConsideration
|
817000 | USD |
CY2020Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
CY2020Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
CY2020Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1215341 | USD |
CY2020Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14685932 | shares |
CY2020Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
58529619 | USD |
CY2020Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2020Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2020Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2020Q2 | kern |
Net Investment Non Current
NetInvestmentNonCurrent
|
246308 | USD |
CY2020Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q3 | kern |
Revenue Frome Consulting
RevenueFromeConsulting
|
331080 | USD |
CY2020Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2020Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
13258707 | shares |
CY2020Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13258707 | shares |
CY2020Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14685932 | shares |
CY2020Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2020Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2020Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2019Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
610902 | USD |
CY2020Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2097502 | USD |
CY2020Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1534 | USD |
CY2019Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
USD | |
CY2019Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-287 | USD |
CY2020Q3 | us-gaap |
Gross Profit
GrossProfit
|
1974067 | USD |
CY2019Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
10879112 | shares |
CY2019Q3 | us-gaap |
Revenues
Revenues
|
3192890 | USD |
CY2019Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
73095 | USD |
CY2019Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-2326332 | USD |
CY2019Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
4212616 | USD |
CY2020Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1739937 | USD |
CY2019Q3 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
73382 | USD |
CY2020Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
7497537 | USD |
CY2019Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2399427 | USD |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4741876 | USD |
CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2326332 | USD |
CY2019Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2326332 | USD |
CY2019Q3 | us-gaap |
Gross Profit
GrossProfit
|
1813189 | USD |
CY2019Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
17899 | USD |
CY2020Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4749157 | USD |
CY2020Q3 | kern |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
778000 | USD |
CY2020Q3 | us-gaap |
Revenues
Revenues
|
3714004 | USD |
CY2020Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-4750691 | USD |
CY2020Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
774313 | USD |
CY2019Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4242454 | USD |
CY2020Q3 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
12668 | USD |
CY2019Q3 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
252809 | USD |
CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
22367289 | USD |
CY2019Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-519739 | USD |
CY2020Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4181159 | USD |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
14757858 | USD |
CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
22947830 | USD |
CY2020Q3 | kern |
Current Contingent Liability
CurrentContingentLiability
|
817000 | USD |
CY2019Q3 | us-gaap |
Business Combination Step Acquisition Equity Interest In Acquiree Percentage
BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
|
0.01 | pure |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
3881386 | USD |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
983731 | USD |
CY2020Q2 | us-gaap |
Other Long Term Debt
OtherLongTermDebt
|
10200236 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
36574406 | USD |
CY2020Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2020Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2020Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2020Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2020Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-09-30 | |
CY2020Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
19685932 | shares |
CY2020Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
57721556 | USD |
CY2020Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
368685 | USD |
CY2020Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
500000 | USD |
CY2020Q2 | us-gaap |
Goodwill
Goodwill
|
20254309 | USD |
CY2020Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
63000 | USD |
CY2020Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
1464 | USD |
CY2020Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
18131627 | USD |
CY2020Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1861534 | USD |
CY2020Q2 | us-gaap |
Assets Current
AssetsCurrent
|
27732703 | USD |
CY2020Q3 | us-gaap |
Goodwill
Goodwill
|
46500030 | USD |
CY2020Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-45842967 | USD |
CY2020Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1170625 | USD |
CY2020Q2 | kern |
Current Contingent Consideration
CurrentContingentConsideration
|
389000 | USD |
CY2020Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2799225 | USD |
CY2020Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
500000 | USD |
CY2019Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1841514 | USD |
CY2020Q3 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2020Q3 | dei |
Document Type
DocumentType
|
10-Q | |
CY2020Q3 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2020Q3 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001755953 | |
CY2020Q3 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2020Q3 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
CY2020Q3 | dei |
Entity File Number
EntityFileNumber
|
001-39096 | |
CY2020Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
4999999 | shares |
CY2020Q3 | us-gaap |
Assets
Assets
|
81334782 | USD |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24155828 | USD |
CY2020Q3 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2020Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
83164840 | USD |
CY2020Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-7000 | USD |
CY2019Q3 | kern |
Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
|
161165 | USD |
CY2020Q3 | us-gaap |
Other Long Term Debt Current
OtherLongTermDebtCurrent
|
10146001 | USD |
CY2020Q3 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
10730021 | USD |
CY2020Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
72906924 | USD |
CY2020Q2 | kern |
Capitalized Software Net
CapitalizedSoftwareNet
|
2629304 | USD |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-9897970 | USD |
CY2020Q3 | us-gaap |
Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
|
12203 | USD |
CY2020Q1 | kern |
Gross Profits
GrossProfits
|
1674327 | USD |
kern |
Gross Profits
GrossProfits
|
3504153 | USD | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.56 | ||
CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
874787 | USD |
CY2019Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.34 | |
CY2019Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4883172 | USD |
kern |
Net Losses
NetLosses
|
-10834156 | USD | |
CY2019Q4 | kern |
Gross Profits
GrossProfits
|
1690964 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8484886 | USD | |
CY2019Q4 | kern |
Cost Of Revenues
CostOfRevenues
|
1615239 | USD |
kern |
Gross Profits
GrossProfits
|
5178480 | USD | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.96 | ||
CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.38 | |
CY2019Q3 | kern |
Cost Of Revenues
CostOfRevenues
|
1379701 | USD |
CY2020Q1 | kern |
Net Losses
NetLosses
|
-4744129 | USD |
CY2020Q1 | kern |
Cost Of Revenues
CostOfRevenues
|
1396219 | USD |
kern |
Cost Of Revenues
CostOfRevenues
|
2994940 | USD | |
kern |
Net Losses
NetLosses
|
-6090027 | USD | |
CY2019Q4 | kern |
Net Losses
NetLosses
|
-3763695 | USD |
CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-2326332 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1234403 | USD | |
CY2019Q3 | kern |
Net Losses
NetLosses
|
-2326332 | USD |
CY2019Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
623501 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
14163128 | USD | |
CY2020Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-4820691 | USD |
CY2019Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
USD | |
CY2020Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-8815 | USD |
CY2020Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-70000 | USD |
CY2020Q2 | kern |
Debt Purchase Price
DebtPurchasePrice
|
15000000 | USD |
CY2020Q2 | us-gaap |
Convertible Debt
ConvertibleDebt
|
17000000 | USD |
CY2020Q1 | kern |
Current Contingent Consideration
CurrentContingentConsideration
|
389000 | USD |
CY2020 | kern |
Fair Value Assumption Expected Terms
FairValueAssumptionExpectedTerms
|
P2Y10M24D | |
CY2020Q3 | kern |
Fair Value Assumption Expected Terms
FairValueAssumptionExpectedTerms
|
P2Y8M1D | |
CY2020Q3 | kern |
Fair Value Assumptions Market Yield Rate
FairValueAssumptionsMarketYieldRate
|
0.280 | pure |
CY2020Q3 | kern |
Fair Value Assumptions Volatility Rate
FairValueAssumptionsVolatilityRate
|
0.68 | pure |
CY2020Q3 | kern |
Fair Value Assumptions Value Of Common Stock
FairValueAssumptionsValueOfCommonStock
|
3.64 | |
CY2020Q3 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
11.50 | |
CY2020Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
17000000 | USD |
CY2020Q3 | kern |
Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
|
70000 | USD |
CY2020Q2 | kern |
Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
|
0.002 | pure |
CY2020Q2 | kern |
Fair Value Assumptions Market Yield Rate
FairValueAssumptionsMarketYieldRate
|
0.239 | pure |
CY2020Q2 | kern |
Fair Value Assumptions Volatility Rate
FairValueAssumptionsVolatilityRate
|
0.45 | pure |
CY2020Q2 | kern |
Fair Value Assumptions Value Of Common Stock
FairValueAssumptionsValueOfCommonStock
|
8.80 | |
CY2020Q2 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
11.50 | |
CY2019Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
17899 | USD |
CY2020Q3 | kern |
Acquisition Of Noncontrolling Interest
AcquisitionOfNoncontrollingInterest
|
USD | |
CY2020Q3 | kern |
Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
|
764351 | USD |
CY2019Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
23837021 | USD |
CY2019Q3 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
4242454 | USD |
CY2020Q3 | us-gaap |
Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions
AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions
|
-70000 | USD |
CY2020Q3 | kern |
Restricted Stock Unit Vesting
RestrictedStockUnitVesting
|
USD | |
CY2020Q3 | kern |
Exchangeable Shares Issued In Acquisition
ExchangeableSharesIssuedInAcquisition
|
25203490 | USD |
CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14257858 | USD |
CY2020Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
USD | |
CY2020Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2470187 | USD |
CY2019Q3 | kern |
Revenues From Software
RevenuesFromSoftware
|
2254480 | USD |
CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.34 | |
CY2019Q3 | kern |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
USD | |
CY2019Q3 | kern |
Revenue Frome Consulting
RevenueFromeConsulting
|
831363 | USD |
CY2019Q3 | kern |
Revenue From Other
RevenueFromOther
|
107047 | USD |
CY2020Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | |
CY2020Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1171022 | USD |
CY2019Q3 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
519739 | USD |
CY2020Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-8815 | USD |
CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
14058412 | shares |
CY2020Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1171022 | USD |
CY2020Q3 | kern |
Revenue From Other
RevenueFromOther
|
228482 | USD |
CY2020Q3 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-3687 | USD |
CY2019Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1742301 | USD |
CY2020Q3 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 - Description of Business, Liquidity and Capital <font><font><font>Resources</font></font></font></font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Description of Business</font></p> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Akerna Corp., herein referred to as we, our or Akerna, through our wholly owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, and solo sciences, inc, or Solo, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses’ compliance with state regulations and to help state-licensed businesses operate in compliance with such laws. We provide our commercial software platforms, MJ Platform<sup>®</sup>, Ample and Trellis<sup>®</sup> to state- or federally-licensed businesses, and our regulatory software platform, Leaf Data Systems<sup>®</sup>, to state government regulatory agencies. Through Solo,</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG</font><font style="font-family: 'Times New Roman'; font-size: 6.67pt; vertical-align: super; line-height: inherit;">™</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">. The integration of MJ Platform<sup>®</sup> and solo*CODE</font><font style="font-family: 'Times New Roman'; font-size: 6.67pt; vertical-align: super; line-height: inherit;">™ </font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">results in technology for consumers and brands that brings a consumer-facing mark designed to highlight authenticity and signify transparency. </font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating our expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our consulting engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets who are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations. </font></p> <p style="margin: 0pt; text-align: justify; text-indent: 36pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </font></p> <p style="margin: 0pt; text-align: justify; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Fiscal Year-End</font><br/></p> <p style="margin: 0pt; text-align: justify; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;"><br/></font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><font style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">On September 25, 2020, our Board of Directors adopted resolutions to change our fiscal year-end from June 30 to December 31, effective for the year ending December 31, 2020. We will cover the transition period from July 1, 2020 to December 31, 2020 by filing an Annual Report on Form 10-K for the transition year ending December 31, 2020. </font></font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><br/></font></font></p> <p style="margin: 0pt; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Liquidity and <font style="line-height: inherit;">Capital <font style="line-height: inherit;">Resources</font></font></font></p> <p style="margin: 0pt; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"><font style="line-height: inherit;"><font style="line-height: inherit;"><br/></font></font></font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Since our i<font style="line-height: inherit;">nception</font>, we have incurred recurring operating losses, used cash in operations, and relied on capital raising transactions to continue ongoing operations. During the three months ended September 30, 2020, we incurred a loss from operations of $<font>5.5</font> million and used cash in operations of $<font>4.2</font> million.<font style="line-height: inherit;"> </font>As of September 30, 2020, we had cash of $<font>14.3</font> million, excluding restricted cash, and working capital of $<font>0.9</font> million.</font></font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"> </font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">During the quarter ended September 30, 2020, the Company incurred a number of <font>one</font>-time, non-recurring expenses of approximately $<font>1.1</font> million. These expenses include business combination expenses, restructuring and other non-recurring charges.<font style="line-height: inherit;"> </font>Additionally, on October 30, 2020, we closed on the public offering of <font>5</font> million shares of common stock with proceeds of approximately $<font>11.0</font> million net of offering costs, which will be used for general corporate purposes. During the three months ended September 30, 2020 we implemented a number of <font>cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $<font>3.0</font> million to $<font>4.0</font> million.<font style="line-height: inherit;"> </font></font><font style="line-height: inherit;"> </font>As a result, we expect that our current working capital is sufficient to fund our operations and commitments for a period of at least <font>twelve</font> months from the date these financial statements are issued.</font></font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"> </font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">In the event the Company requires additional liquidity, the Company can further reduce or defer expenses. More specifically, the Company could implement certain discretionary cost reduction initiatives relating to our spend on employee travel and entertainment, consulting costs and marketing expenses, negotiate deferred salary arrangements, furlough employees or reduce headcount or negotiate extensions of payments of rent and utilities.<font style="line-height: inherit;"> </font>The Company also believes it has access to capital through future debt or equity offerings and could be successful in renegotiating the maturity dates or conversion option relating to its current outstanding notes payable, although no assurance can be provided that we would be successful in these efforts.<font style="line-height: inherit;"> </font>Further, the potential continues to exist that our $<font>2</font> million PPP loan could be forgiven. Management will continue to evaluate our liquidity and capital resources. </font></font></p> </div> | |
CY2020Q3 | kern |
Conversion Of Exchangeable Share To Common Stock
ConversionOfExchangeableShareToCommonStock
|
4798271 | USD |
CY2020Q3 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
12450 | USD |
CY2020Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5704806 | USD |
CY2020Q3 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
624863 | USD |
CY2020Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
CY2020Q3 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
245329 | USD |
CY2020Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-12668 | USD |
CY2019Q3 | kern |
Capitalized Software Included In Accrued Expense
CapitalizedSoftwareIncludedInAccruedExpense
|
USD | |
CY2019Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
USD | |
CY2020Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1758826 | USD |
CY2019Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1379701 | USD |
CY2020Q3 | kern |
Revenues From Software
RevenuesFromSoftware
|
3154442 | USD |
CY2020Q3 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
74023 | USD |
CY2019Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD | |
CY2020Q3 | kern |
Change In Fair Value Of Convertible Debt
ChangeInFairValueOfConvertibleDebt
|
-778000 | USD |
CY2020Q3 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
25200000 | USD |
CY2020Q2 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
7493975 | USD |
CY2020Q3 | us-gaap |
Other Long Term Debt
OtherLongTermDebt
|
5481599 | USD |
CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
USD | |
CY2019Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2326332 | USD |
CY2019Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1508217 | USD |
CY2020Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9298 | USD |
CY2020Q3 | kern |
Capitalized Software Included In Accrued Expense
CapitalizedSoftwareIncludedInAccruedExpense
|
807218 | USD |
CY2020Q3 | us-gaap |
Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
|
4901 | USD |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
464575 | USD |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
426495 | USD |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
421418 | USD |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
439633 | USD |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
918847 | USD |
CY2020Q3 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
226687 | USD |
CY2019Q3 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
36000 | USD |
CY2020Q3 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
273000 | USD |
CY2020Q3 | kern |
Preferred Stock Liquidation Description
PreferredStockLiquidationDescription
|
special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $1.00. | |
CY2020Q2 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
265000 | USD |
CY2019Q3 | kern |
Conversion Of Exchangeable Share To Common Stock
ConversionOfExchangeableShareToCommonStock
|
USD | |
CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5523470 | USD |
CY2020Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5678242 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2109190 | USD | |
CY2019Q3 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
4130000 | USD |
CY2020Q3 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-4686000 | USD |
CY2020Q3 | kern |
Revenue From Business Combinations
RevenueFromBusinessCombinations
|
1.2 | USD |
CY2020Q3 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
|
149000 | USD |
CY2020Q3 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
|
549000 | USD |
CY2020Q3 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
|
30433000 | USD |
CY2020Q3 | us-gaap |
Acquisition Costs
AcquisitionCosts
|
1000000 | USD |
CY2020Q3 | us-gaap |
Cash
Cash
|
5724000 | USD |
CY2020Q3 | kern |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Furniture Fixtures And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFurnitureFixturesAndEquipment
|
1327000 | USD |
CY2020Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2667349 | shares |
CY2020Q3 | us-gaap |
Business Combination Contingent Consideration Arrangements Description
BusinessCombinationContingentConsiderationArrangementsDescription
|
We acquired 100% of the stock of Ample Organics by issuing 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, for an aggregate value of $25.2 million. The exchangeable shares are economically equivalent to shares of Akerna common stock. In addition to the stock consideration, we paid $5.7 million in cash, which was used to settle all of Ample's then outstanding debt and transaction costs. The agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration was recorded as the estimated fair value of $0.8 million as of the acquisition date and will be adjusted to the estimated fair value in each subsequent reporting period until settlement. | |
CY2020Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2020Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
Akerna Corp. | |
CY2020Q3 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2020Q2 | us-gaap |
Assets
Assets
|
58529619 | USD |
CY2020Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41101091 | USD |
CY2020Q2 | us-gaap |
Liabilities
Liabilities
|
21955213 | USD |
CY2020Q3 | us-gaap |
Assets Current
AssetsCurrent
|
19032696 | USD |
CY2020Q2 | us-gaap |
Other Long Term Debt Current
OtherLongTermDebtCurrent
|
6135364 | USD |
CY2020Q3 | kern |
Conversion Of Exchangeable Shares To Common Stock
ConversionOfExchangeableSharesToCommonStock
|
USD | |
CY2019Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
21759734 | USD |
CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
580541 | USD |
CY2020Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
17000000 | USD |
CY2020Q2 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
14131000 | USD |
CY2020Q3 | kern |
Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
|
-778000 | USD |
CY2020Q3 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
445000 | USD |
CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
|
0.0001 | |
CY2020Q3 | kern |
Net Income Loss From Bussiness Combinations
NetIncomeLossFromBussinessCombinations
|
0.4 | USD |
CY2020Q3 | kern |
Preliminary Fair Value Of Consideration Transferred
PreliminaryFairValueOfConsiderationTransferred
|
31744000 | USD |
CY2020Q3 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
|
31744000 | USD |
CY2020Q3 | kern |
Exchangeable Shares Value
ExchangeableSharesValue
|
4798271 | USD |
CY2020Q3 | kern |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses
|
978000 | USD |
CY2019Q3 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-4185000 | USD |
CY2020Q3 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2019Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6029268 | shares |
CY2020Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10912224 | shares |
CY2020Q3 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
392000 | USD |
CY2019Q3 | kern |
Gross Profits
GrossProfits
|
1813189 | USD |
CY2019Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3601714 | USD |
kern |
Cost Of Revenues
CostOfRevenues
|
4391159 | USD | |
CY2020Q3 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
|
917000 | USD |
CY2019Q3 | us-gaap |
Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
|
USD | |
CY2019Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
4242454 | USD |
CY2020Q3 | kern |
Cash Acquired In Business Combination
CashAcquiredInBusinessCombination
|
5067740 | USD |
CY2020Q3 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of Credit Risk</font></p> <p style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 8pt 0pt 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk.</font><font class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;"></font></p> <p style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 8pt 0pt 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;"><font class="ng-scope" style="/* background-color: #ffffff;">During the three months ended<font style="line-height: inherit;"> </font><font>September 30, 2020,</font> and<font style="line-height: inherit;"> </font><font class="ng-scope"><font>2019</font></font>, </font><font class="ng-scope"><font style="border-left: none; border-right: none; line-height: inherit;" class="ng-scope"><font>one</font></font></font><font style="/* background-color: #ffffff;"> government client accounted for </font><font class="ng-scope"><font>17</font></font><font style="background-color: #ffff00;"><font class="ng-scope" style="background-color: #ffffff;">% and <font class="ng-scope"><font>24</font></font>% of total revenues, respectively.<font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> </font>As of September<font> 30, 2020</font>, </font></font><font class="ng-scope"><font style="border-left: none; border-right: none; line-height: inherit;" class="ng-scope"><font>two</font></font></font><font class="ng-scope" style="/* background-color: #ffffff;"> government clients accounted f<font>or a total of <font class="ng-scope" style="line-height: inherit;"><font>38</font>% and <font>20</font></font></font><font><font class="ng-scope" style="line-height: inherit;">%</font> </font>of net accounts receivable and <font>one</font> government client had outstanding receivables as of September 30, 2019, which accounted for <font>63</font>% of net accounts receivable. </font></font></p> </div> | |
CY2020Q3 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | Segment |
CY2020Q3 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
2000000 | USD |
CY2020Q3 | kern |
Non Recurring Expenses
NonRecurringExpenses
|
1100000 | USD |
CY2020Q3 | kern |
Working Capital
WorkingCapital
|
900000 | USD |
CY2020Q2 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
10254374 | USD |
CY2020Q3 | kern |
Percentage Of Acquired Entity Ownership Acquired
PercentageOfAcquiredEntityOwnershipAcquired
|
1.00 | pure |
CY2020Q3 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
15515357 | USD |
CY2020Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
2200000 | USD |
CY2020Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
200000 | USD |
CY2020Q3 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
451925 | shares |
CY2020Q3 | kern |
Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
|
389000 | USD |
CY2019Q3 | kern |
Change In Fair Value Of Convertible Debt
ChangeInFairValueOfConvertibleDebt
|
USD | |
CY2019Q3 | kern |
Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
|
USD | |
CY2019Q3 | kern |
Special Voting Preferred Stock Issued In Business Combination
SpecialVotingPreferredStockIssuedInBusinessCombination
|
USD | |
CY2020Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</font></p> <p style="margin: 8pt 0pt 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. Actual results could differ materially from those estimates. </font></p> </div> | |
CY2020Q3 | kern |
Shareholders Exchanged
ShareholdersExchanged
|
627225 | shares |
CY2020Q3 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
3790000 | USD |
CY2020Q1 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
291000 | USD |
CY2020Q3 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Reclassifications and Revisions</font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;" class="ng-scope">Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation. Additionally, certain prior year financial statement amounts have been revised to correct misstatements in the prior year, please refer to Note <font>9</font> for additional information regarding the corrections.</font></p> </div> | |
CY2020Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
200000 | USD |
CY2020Q3 | kern |
Cost Reduction Initiatives Description
CostReductionInitiativesDescription
|
cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $3.0 million to $4.0 million. | |
CY2020Q3 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
681419 | USD |
CY2019Q3 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
278208 | USD |
CY2020Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
663 | USD |
CY2020Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
41925 | USD |
CY2020Q3 | kern |
Net Investment Non Current
NetInvestmentNonCurrent
|
244774 | USD |
CY2019Q3 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
292272 | USD |
CY2019Q3 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
161165 | USD |
CY2019Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3142174 | USD |
CY2019Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1974 | USD |
CY2020Q3 | us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
1534 | USD |
CY2020Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-296802 | USD |
CY2019Q3 | kern |
Cash Acquired In Business Combination
CashAcquiredInBusinessCombination
|
USD | |
CY2019Q3 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
USD | |
CY2020Q3 | kern |
Special Voting Preferred Stock Issued In Business Combination
SpecialVotingPreferredStockIssuedInBusinessCombination
|
25203490 | USD |
CY2019Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
274566 | USD |
CY2020Q3 | kern |
Acquisition Of Noncontrolling Interests
AcquisitionOfNoncontrollingInterests
|
4695437 | USD |
CY2019Q3 | kern |
Acquisition Of Noncontrolling Interests
AcquisitionOfNoncontrollingInterests
|
USD | |
CY2019Q3 | us-gaap |
Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
|
USD | |
CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
24655828 | USD |